Nitric oxide is involved in stimulation of tumor growth

Oncology Reports

Volumn 4, Issue 5, 1997, Pages 1107-1111

  Jasnis, Maria Adela ^a   Giri, Juan ^a   Davel, Lilia ^a  

^a Instituto de Oncologia Angel H Roffo   (Argentina)

Author keywords

Angiogenesis; Nitric oxide

Indexed keywords

ARGININE; GAMMA INTERFERON; N(G) NITROARGININE; NITRIC OXIDE;

ADOLESCENT; ANGIOGENESIS; ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 0030790711     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.5.1107     Document Type: Article

References (28)

1. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC and Moncada S: Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92: 4392-4396, 1995.
2. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V and Moncada S: Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54: 1352-1354, 1994.
3. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG and Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-44, 1995.
4. Murata J, Betz Corradin S, Janzer RC and Juikkerat-Jeanneret L: Tumor cells suppress cytokine induced nitric oxide (NO) production in cerebral endothelial cells. Int J Cancer 59: 699-705, 1994.
5. Sotomayor EM, Di Napoli MR, Calderon C, Colsky A, Fu Y and Lopez DM: Decreased macrophage-mediated cytotoxicity in mammary-tumor bearing mice is related to alteration of nitric oxide production and/or release. Int J Cancer 60: 660-667, 1995.
6. Alleva DG, Burger CJ and Elgert KD: Tumor-induced regulation of suppressor macrophage nitric oxide and TNFα production. Role of tumor-derived IL-10, TGFβ and prostaglandin E2. J Immunol 153: 1674-1686, 1994.
7. Lejeune P, Lagadec P, Onier N, Pinard D, Ohshima H and Jeannin JF: Nitric oxide involvement in tumor-induced immunosuppression. J Immunol 152: 5077-5083, 1994.
8. Rollo EE, Laskin DL and Denhardt DT: Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW 264.7 macrophages. J Leukocyte Biol 60: 397-207, 1996.
9. Nathan CF: Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064, 1992.
10. Folkman J: Tumor angiogenesis. Adv Cancer Res 43: 175-208, 1985.
11. Ellis LM and Fidler IJ: Angiogenesis and metastasis. Eur J Cancer 32A: 2451-2460, 1996.
12. Miguez M, Davel L and Lustig ES: Lymphocyte-induced angiogenesis: correlation with the metastatic incidence of two mammary adenocarcinomas. Invasion Metastasis 6: 313-320, 1986.
13. Ziehe M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P and Ledcia F: Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94: 2036-2044, 1994.
14. Bouck N, Stellmach V and Hsu S: How tumors become angiogenic. Adv Cancer Res 69: 135-174, 1996.
15. Marshall JL and Hawkins JM: The clinical experience with antiangiogenic agents. Breast Cancer Res Treat 36: 253-261, 1995.
16. Pipili-Synetos E, Sakkoula E, Haralabopoulos G, Andriopoulou P, Peristeris P and Maragoudakis ME: Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 111: 894-902, 1994.
17. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA and Koch AE: Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide synthase-dependent effector mechanism. Proc Natl Acad Sci USA 91: 4190-4194, 1994.
18. Colombo L, Bonaparte Y, Klein S and Stillitani Y: Seleccion in vivo de una linea tumoral con alla incidencia de metastasis pulmonares. Medicina-Buenos Aires 40: 827-828, 1980.
19. Bal de Kier Joffe E, Puricelli L, Vidal M and Sacerdote de Lustig E: Characterization of two murine mammary adenocarcinoma tumor with different metastatic ability. J Exp Clin Cancer Res 2: 151-160, 1983.
20. Moncada S, Palmer RMJ and Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142, 1991.
21. Granger DL, Hibbs JB, Perfect JR and Durack DT: Metabolic fate of L-arginine inha lation to microbiostatic capability of murine macrophages. J Clin Invest 85: 264-273, 1990.
22. Davel L, Miguez M and Sacerdote de Lustig E: Angiogenesis induction by lymphocytes from tumor bearing mice in a syngeneic combination. Transplantation 37: 327-328, 1984.
23. Stuehr DJ and Nathan CF: Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169: 1543-1555, 1989.
24. Mantovani A, Bottazzi B, Colotta S, Sozzani S and Rouco L: The origin and function of tumor associated macrophaes. Immunol Today 13: 265-270, 1992.
25. G-methyl-L-Arginine, an inhibitor of nitric oxide synthesis on IL-2 induced capillary leakage and antitumor responses in healthy and tumor bearing mice. Cancer Immunol Immunother 42: 38-46, 1996.
26. Xie K, Huang S, Dong Z, Juang S, Wang Y and Fidler IJ: Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene. J Natl Cancer Inst 89: 421-427, 1997.
27. Ziche M, Jones J and Gullino PM: Role of prostaglandin E and copper in angiogenesis. J Natl Cancer Inst 69: 475-482, 1982.
28. Dusseau JW, Hutchins PM and Malbasa DS: Stimulation of angiogenesis by adenosine on chick chorioalantoic membrane. Circ Res 59: 163-170, 1986.